title: Attenuation of protease activity in chronic wound fluid with bisphosphonate-functionalised hydrogels.
abstract: Chronic ulcers are an important and costly medical issue, imposing considerable pain, reduced mobility and decreased quality of life. The common pathology in these chronic wounds is excessive proteolytic activity, resulting in degradation of key factors critical to the ulcer's ability to heal. Matrix metalloproteinases (MMPs), a large family of zinc-dependent endopeptidases, have been shown to have increased activity in chronic wound fluid (CWF), with many authors suggesting that they need to be inhibited for the ulcer to heal. The studies we report here show that the excessive MMP activity in CWF can be inhibited with the bisphosphonate alendronate, in the form of a sodium salt, a functionalised analogue, and tethered to a poly(2-hydroxy methacrylate) (PHEMA) hydrogel. Furthermore, these functionalised alendronate hydrogels appear to be biologically inert as assessed in a three-dimensional ex vivo human skin equivalent model. Together, these results highlight the potential use of a tethered MMP inhibitor to inhibit protease activity in wound fluid. This approach may improve wound healing as it still allows MMPs to remain active in the upper cellular layers of the ulcer bed where they perform vital roles in wound healing; thus may offer an attractive new device-orientated wound therapy.
authors.affiliation: Tissue Repair and Regeneration Program, Institute of Health and Biomedical Innovation, Queensland University of Technology, Kelvin Grove, Brisbane, Queensland, Australia. e.rayment@qut.edu.au
authors.forename: Erin A
authors.initials: EA
authors.lastname: Rayment
authors.forename: Tim R
authors.initials: TR
authors.lastname: Dargaville
authors.forename: Gary K
authors.initials: GK
authors.lastname: Shooter
authors.forename: Graeme A
authors.initials: GA
authors.lastname: George
authors.forename: Zee
authors.initials: Z
authors.lastname: Upton
mesh_terms: D001826:Body Fluids / Q000378:metabolism*; D004164:Diphosphonates / Q000008:administration & dosage* / Q000737:chemistry; D004337:Drug Carriers / Q000737:chemistry*; D004789:Enzyme Activation / Q000187:drug effects; D006801:Humans; D020100:Hydrogels / Q000737:chemistry*; D008422:Materials Testing; D061965:Matrix Metalloproteinase Inhibitors; D014456:Ulcer / Q000188:drug therapy* / Q000201:enzymology*; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D004164:Diphosphonates; D004337:Drug Carriers; D020100:Hydrogels; D061965:Matrix Metalloproteinase Inhibitors